<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rom S</submitter><funding>NIMH NIH HHS</funding><funding>NIAAA NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>878</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4548080</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>Multifactorial mechanisms comprising countless cellular factors and virus-encoded transactivators regulate the transcription of HIV-1 (HIV). Since poly(ADP-ribose) polymerase 1 (PARP-1) regulates numerous genes through its interaction with various transcription factors, inhibition of PARP-1 has surfaced recently as a powerful anti-inflammatory tool. We suggest a novel tactic to diminish HIV replication via PARP-1 inhibition in an in vitro model system, exploiting human primary monocyte-derived macrophages (MDM). PARP-1 inhibition was capable to lessen HIV replication in MDM by 60-80% after 7 days infection. Tat, tumor necrosis factor α (TNFα), and phorbol 12-myristate 13-acetate (PMA) are known triggers of the Long Terminal Repeat (LTR), which can switch virus replication. Tat overexpressi</pubmed_abstract><journal>Frontiers in microbiology</journal><pubmed_title>The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity.</pubmed_title><pmcid>PMC4548080</pmcid><funding_grant_id>R37 AA015913</funding_grant_id><funding_grant_id>R21 NS087385</funding_grant_id><funding_grant_id>R01 MH065151</funding_grant_id><funding_grant_id>R01 AA015913</funding_grant_id><pubmed_authors>Persidsky Y</pubmed_authors><pubmed_authors>Rom S</pubmed_authors><pubmed_authors>Dykstra H</pubmed_authors><pubmed_authors>Reichenbach NL</pubmed_authors></additional><is_claimable>false</is_claimable><name>The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity.</name><description>Multifactorial mechanisms comprising countless cellular factors and virus-encoded transactivators regulate the transcription of HIV-1 (HIV). Since poly(ADP-ribose) polymerase 1 (PARP-1) regulates numerous genes through its interaction with various transcription factors, inhibition of PARP-1 has surfaced recently as a powerful anti-inflammatory tool. We suggest a novel tactic to diminish HIV replication via PARP-1 inhibition in an in vitro model system, exploiting human primary monocyte-derived macrophages (MDM). PARP-1 inhibition was capable to lessen HIV replication in MDM by 60-80% after 7 days infection. Tat, tumor necrosis factor α (TNFα), and phorbol 12-myristate 13-acetate (PMA) are known triggers of the Long Terminal Repeat (LTR), which can switch virus replication. Tat overexpressi</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2025-04-26T01:07:09.274Z</modification><creation>2019-03-27T01:57:15Z</creation></dates><accession>S-EPMC4548080</accession><cross_references><pubmed>26379653</pubmed><doi>10.3389/fmicb.2015.00878</doi></cross_references></HashMap>